British Journal of Nutrition, 2024 The protective effect of higher serum triacylglycerol (51:4) levels against Parkinson’s disease Jing Y., Su J., Zhu H. et al. Olink Target 96NeurologyNutritional SciencePathophysiologyPlasma | | | | |
BJPsych Open, 2024 Depression in childhood to early adulthood and respiratory health in early adulthood Wang G., Hallberg J., Hernandez-Pacheco N. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Frontiers in Molecular Biosciences, 2024 Proteomics analysis of extracellular vesicles for biomarkers of autism spectrum disorder Ali Moussa H., Shin K., de la Fuente A. et al. Olink Target 96NeurologyPatient StratificationEV Lysate | | | | |
Molecular Neurodegeneration, 2024 CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals del Campo M., Quesada C., Vermunt L. et al. Olink Target 96NeurologyPatient StratificationCSF | | | | |
Journal of the Neurological Sciences, 2024 Multi-Omic characterization of the effects of Ocrelizumab in patients with relapsing-remitting multiple sclerosis Kornilov S., Price N., Gelinas R. et al. Olink Explore 3072/384NeurologyPathophysiologyPlasma | | | | |
Nature Medicine, 2024 Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial Li R., Villa N., Yu X. et al. Olink Target 96OncologyImmunotherapyPathophysiologyUrine | | | | |
Nature Communications, 2024 Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker Martins T., Kaymak D., Tatari N. et al. Olink Target 96OncologyImmunotherapyPathophysiologyMouse Plasma | | | | |
American Journal of Respiratory and Critical Care Medicine, 2024 Unsupervised Classification of the Host Response Identifies Dominant Pathobiological Signatures of Sepsis in Sub-Saharan Africa Cummings M., Lutwama J., Owor N. et al. Olink Target 96Infectious DiseasesPatient StratificationSerum | | | | |
Alzheimer's & Dementia, 2024 Assessing polyomic risk to predict Alzheimer's disease using a machine learning model Ngai T., Willett J., Waqas M. et al. Olink Explore 3072/384NeurologyPatient StratificationPlasma | | | | |
Brain, 2024 Perivascular space dysfunction in cerebral small vessel disease is related to neuroinflammation Hong H., Tozer D., Chen Y. et al. Olink Target 96Neurovascular DiseasesPathophysiologySerum | | | | |
ERJ Open Research, 2024 Targeted proteomics in extracellular vesicles identifies biomarkers predictive for therapeutic response in sarcoidosis Kraaijvanger R., Janssen Bonás M., Paspali I. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationEV Lysate | | | | |
Acta Diabetologica, 2024 Clinical, genomic, and proteomic perspectives in the analysis of comorbid conditions in type 2 diabetes mellitus: a retrospective study Villikudathil A., Mc Guigan D., English A. Olink Target 96Metabolic DiseasesPatient StratificationBlood | | | | |
Molecular Therapy - Methods & Clinical Development, 2024 Comparative assessment of the transduction efficiency and safety associated with the delivery of AAV9-GFP vector via lumbar puncture to cynomolgus macaques with and without anti-AAV9 pre-existing antibodies Guibinga G., Do J., Chu B. et al. Olink Target 96NeurologyPathophysiologyMonkey PlasmaMonkey CSF | | | | |
ESC Heart Failure, 2024 Causal correlations between inflammatory proteins and heart failure: A two‐sample Mendelian randomization analysis Zhu X., Liu G., Peng Y. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Journal of Experimental & Clinical Cancer Research, 2024 Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors Jirovec E., Quixabeira D., Clubb J. et al. Olink Target 96Olink Target 48OncologyImmunotherapyPathophysiologySerum | | | | |
BMC Medicine, 2024 BMI trajectories from birth to young adulthood associate with distinct cardiometabolic profiles Wang G., Wei D., Kebede Merid S. et al. Olink Target 96CVDMetabolic DiseasesPathophysiologyPlasma | | | | |
Circulation: Heart Failure, 2024 Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy Tahir U., Kolm P., Kwong R. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
Journal of Crohn's and Colitis, 2024 Characterisation of IBD heterogeneity using serum proteomics: A multicentre study Salomon B., Sudhakar P., Bergemalm D. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationSerum | | | | |
MedComm, 2024 An inflammatory cytokine signature predicts IgA nephropathy severity and progression Chen L., Chen X., Cai G. et al. Olink Target 96NephrologyPatient StratificationUrine | | | | |
European Heart Journal Open, 2024 Vascular and inflammatory biomarkers of cardiovascular events in non-steroidal anti-inflammatory drug (NSAID) users Vaja R., Ferreira P., Portas L. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesCVDPathophysiologySerum | | | | |